Page-2 of COVAXIN Vaccine Current Affairs, GK & News

PM Takes First Dose of COVID-19 Vaccine

March 1, 2021

The Prime Minister of India, Narendra Modi, takes first dose of COVID-19 vaccine on March 1, 2021 at AIIMS, New Delhi. After vaccination, he appealed to those people who are eligible to get their vaccination done. Covid-19 Vaccination in India The national vaccination programme to for the virus called “SARS-CoV-2” which has caused ongoing Covid-19 ..

Month: 

Category: 

Topics:  • • • •

SII’s Covishield gets emergency-use nod from DGCI

January 2, 2021

The Subject Expert committee that is advising the Drug Controller General of India (DCGI) recommended restricted Emergency Use Authorisation for COVISHIELD. COVISHIELD vaccine was developed by Serum Institute of India. Who manufactures COVISHIELD? The COVISHIELD the vaccine is developed by the University of Oxford and the British Pharmaceutical major Astra Zeneca. In India, the vaccine ..

Month: 

Category: 

Topics:  • • • • • • • •

COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India

November 17, 2020

On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to be held in partnership with the Indian Council of Medical Research. The trials are the largest clinical trials that is conducted for COVID-19 vaccine in the country. ..

Month: 

Category: 

Topics:  • • • • • • •

Indigenously Developed ‘COVAXIN’ gets DCGI approval for Human Clinical Trials

June 30, 2020

The Drug Controller General of India (DCGI) has given approval for Phase I and Phase II human clinical trials for COVID-19 vaccine ‘COVAXIN’. In association with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), COVAXIN is developed by Hyderabad based vaccine & bio-therapeutics manufacturer-Bharat Biotech.  At NIV Pune, the ..

Month: 

Category: 

Topics:  • • • • • • • • •